2,3-Dimethyl-2H-indazol-6-amine hydrochloride

Catalog No. :
ACJKZL051
CAS No. :
635702-60-2
Molecular Formula :
C9H12ClN3
Molecular Weight :
197.67

IUPAC Name:2,3-dimethyl-2H-indazol-6-amine hydrochloride

2,3-Dimethyl-2H-indazol-6-amine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g97%$104.00Login to see priceIn stockInquiry
500g97%$519.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,3-Dimethyl-2H-indazol-6-amine hydrochloride
IUPAC Name2,3-dimethyl-2H-indazol-6-amine hydrochloride
MDL No.MFCD09258896
Molecular FormulaC9H12ClN3
Molecular Weight197.67
SMILESCl.CN1N=C2C=C(N)C=CC2=C1C
InChI KeyDYTQJZDNKWQSLS-UHFFFAOYSA-N
Synonym635702-60-2 | 2,3-DIMETHYL-2H-INDAZOL-6-AMINE HYDROCHLORIDE | 2,3-dimethyl-6-amino-2H-indazole hydrochloride | 2,3-Dimethyl-2H-indazol-6-amine HCl | 2,3-dimethylindazol-6-amine;hydrochloride | MFCD17014819 | 2H-Indazol-6-amine, 2,3-dimethyl-, hydrochloride (1:1) | 9399
CAS No.635702-60-2
PubChem CID46864001

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACJKZL051 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOPZA481 route compound structure diagram
    ACOPZA481444731-73-1 In Stock
  2. Then
  3. ACJKZL051 route product structure diagram
    ACJKZL051635702-60-2 In Stock
Inquiry

2. ACJKZL051 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACOPZA481 route compound structure diagram
    ACOPZA481444731-73-1 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACJKZL051 route product structure diagram
    ACJKZL051635702-60-2 In Stock
Inquiry

Comments (0)